(Q43883973)

27 November 2017

title

Matrix and serine protease expression during leukemic cell differentiation induced by aclacinomycin and all-trans-retinoic acid (English)

1 reference

27 November 2017

1 reference

1 reference

0 references

Laetitia Devy

1

1 reference

27 November 2017

Patrick Hollender

2

1 reference

27 November 2017

Carine Munaut

3

1 reference

27 November 2017

Alain Colige

4

1 reference

27 November 2017

Roselyne Garnotel

5

1 reference

27 November 2017

Jean Michel Foidart

6

1 reference

27 November 2017

Agnès Noël

7

1 reference

27 November 2017

Pierre Jeannesson

8

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

27 November 2017

published in

Biochemical Pharmacology

1 reference

27 November 2017

volume

63

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

179-189

1 reference

How do normal and leukemic white blood cells egress from the bone marrow? Morphological facts and biochemical riddles

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900848-6

Through and beyond the wall: late steps in leukocyte transendothelial migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900848-6

Infiltrative capacity of T leukemia cell lines: a distinct functional property coupled to expression of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinases-1 (TIMP-1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900848-6

Mechanisms for pro matrix metalloproteinase activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900848-6

Cell migration through extracellular matrix: membrane-type metalloproteinases make the way

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900848-6

Leukolysin/MMP25/MT6-MMP: a novel matrix metalloproteinase specifically expressed in the leukocyte lineage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900848-6

Expression and function of adhesion receptors in acute myelogenous leukemia: parallels with normal erythroid and myeloid progenitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900848-6

Abnormal integrin-mediated regulation of chronic myelogenous leukemia CD34+ cell proliferation: BCR/ABL up-regulates the cyclin-dependent kinase inhibitor, p27Kip, which is relocated to the cell cytoplasm and incapable of regulating cdk2 activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900848-6

Batimastat, a potent matrix mealloproteinase inhibitor, exhibits an unexpected mode of binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900848-6

Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900848-6

Phorbol ester-induced promyelocytic leukemia cell adhesion to marrow stromal cells involves fibronectin specific alpha 5 beta 1 integrin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900848-6

Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900848-6

Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900848-6

Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900848-6

Plasminogen activation in human leukemia and in normal hematopoietic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900848-6

Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900848-6

Unstimulated human acute myelogenous leukemia blasts secrete matrix metalloproteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900848-6

Production and activation of matrix metalloprotease-9 (MMP-9) by HL-60 promyelocytic leukemia cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900848-6

Enhanced migration of the acute promyelocytic leukemia cell line NB4 under in vitro conditions during short-term all-trans-retinoic acid treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900848-6

Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900848-6

Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900848-6

Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900848-6

Stimulated production of urokinase and plasminogen activator inhibitor-2 by the human promyelocytic leukemia cell line HL-60

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900848-6

Interferons and retinoids enhance and dexamethasone suppresses urokinase-mediated plasminogen activation in promyelocytic leukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900848-6

Dexamethasone does not counteract the response of acute promyelocytic leukaemia cells to all-trans retinoic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900848-6

The effect of dexamethasone on functional properties of HL60 cells during all-trans retinoic acid induced differentiation. Are there implications for the retinoic acid syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900848-6

Tissue inhibitors of matrix metalloproteinases in cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900848-6

10.1016/S0006-2952(01)00848-6

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference